FINWIRES · TerminalLIVE
FINWIRES

Beijing Chunlizhengda Medical Logs 6% Rise in Q1 Profit

By

-- Beijing Chunlizhengda Medical Instruments (HKG:1858, SHA:688236) booked 61.7 million yuan in attributable profit for the first quarter of 2026, up 6% from 58.1 million yuan a year earlier, according to a Hong Kong bourse filing Wednesday.

The orthopedic medical device manufacturer's Hong Kong shares fell over 15% in late morning trade Thursday.

Earnings per share were 0.16 yuan, compared with 0.15 yuan in the prior year period.

Revenue fell 5.6% year on year to 217 million yuan, figures showed.

Related Articles

Asia

Market Chatter: ASX's Equity Post-Trade Pricing Model Changes May Increase Revenue, UBS Says

Changes to ASX's (ASX:ASX) equity post-trade pricing model might raise revenues even if turnover moderates, according to UBS analyst Kieren Chidgey, the Australian Financial Review reported Thursday.Chidgey increased earnings forecasts by around 6% across fiscal year 2027 and fiscal year 2028. He expects futures revenue to exceed market forecasts by 10% to 11% over these years.UBS upgraded its recommendation to buy and raised the price target to AU$65.20 per share.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$ASX:ASX
Asia

China Railway Construction's Profit Falls 15% in Q1; Hong Kong Shares Slip 3%

China Railway Construction (HKG:1186, SHA:601186) posted net profit attributable to shareholders of 4.39 billion yuan for the first quarter, down 15% from 5.15 billion yuan a year earlier, according to a Wednesday Hong Kong bourse filing.The railway infrastructure developer's Hong Kong shares declined 3% in Thursday afternoon trade.Earnings per share came in at 0.28 yuan, compared with 0.34 yuan a year earlier.Revenue fell 9.8% to 231.6 billion yuan from 256.8 billion yuan in the prior-year period.

$HKG:1186$SHA:601186
Asia

Mphasis Clocks Gains in Fiscal Q4 Consolidated Profit; Shares Up 3%

Mphasis (NSE:MPHASIS, BOM:526299) recorded a rise in its consolidated attributable profit to 5.10 billion Indian rupees in the fiscal fourth quarter ended March 31 from 4.46 billion rupees a year ago.The company's shares were up nearly 3% in Thursday's trade.Earnings per share climbed to 26.68 rupees compared with the year-ago figure of 23.41 rupees, according to a Wednesday filing to the Indian stock exchanges by the technology company.Revenue from operations in fiscal Q4 increased to 42.4 billion rupees from 37.1 billion rupees a year earlier.The board recommended a final dividend of 62 rupees per share for the fiscal year ended March 31.

$BOM:526299$NSE:MPHASIS
Beijing Chunlizhengda Medical Logs 6% Rise in Q1 Profit | FINWIRES